Quadrant Capital Group LLC Alkermes Plc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 3,806 shares of ALKS stock, worth $107,900. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,806

Previous 3,132 21.52%

Holding current value

$107,900

Previous $75,000 41.33%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$23.01 - $28.55 $15,508 - $19,242	674 Added 21.52%	3,806 $106,000
Q2 2024 Aug 12, 2024	BUY	$23.21 - $27.24 $9,933 - $11,658	428 Added 15.83%	3,132 $75,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $63,808 - $78,697	2,417 Added 842.16%	2,704 $73,000
Q4 2023 Feb 08, 2024	BUY	$23.37 - $28.68 $2,804 - $3,441	120 Added 71.86%	287 $7,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $244 - $287	9 Added 5.7%	167 $4,000
Q2 2022 Aug 09, 2022	SELL	$26.4 - $30.54 $105 - $122	-4 Reduced 2.47%	158 $5,000
Q4 2021 Feb 01, 2022	SELL	$21.47 - $32.08 $450 - $673	-21 Reduced 11.48%	162 $4,000
Q3 2021 Nov 12, 2021	BUY	$23.37 - $32.13 $350 - $481	15 Added 8.93%	183 $6,000
Q2 2021 Aug 09, 2021	BUY	$18.78 - $25.15 $187 - $251	10 Added 6.33%	168 $4,000
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $1,492 - $2,143	97 Added 159.02%	158 $3,000
Q3 2020 Nov 13, 2020	BUY	$16.16 - $20.66 $985 - $1,260	61 New	61 $1,000
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $18,900 - $27,562	-1,420 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $18,545 - $30,160	1,420 New	1,420 $20,000
Q3 2019 Oct 24, 2019	SELL	$19.51 - $24.28 $19,549 - $24,328	-1,002 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$21.47 - $37.33 $19,516 - $33,932	909 Added 977.42%	1,002 $22,000
Q1 2019 Apr 29, 2019	SELL	$28.4 - $36.49 $766 - $985	-27 Reduced 22.5%	93 $2,000
Q4 2018 Jan 17, 2019	BUY	$27.94 - $44.61 $111 - $178	4 Added 3.45%	120 $1,000
Q3 2018 Oct 29, 2018	BUY	$38.6 - $46.12 $579 - $691	15 Added 14.85%	116 $2,000
Q2 2018 Aug 09, 2018	SELL	$40.56 - $51.36 $486 - $616	-12 Reduced 10.62%	101 $2,000
Q4 2017 Jan 31, 2018	SELL	$47.69 - $55.39 $2,098 - $2,437	-44 Reduced 28.03%	113 $3,000
Q2 2017 Aug 15, 2017	BUY	N/A	157	157 $6,000

Others Institutions Holding ALKS

# of Institutions

358

Shares Held

181M

Call Options Held

168K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.66B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Alkermes Plc. Transaction History